Andrew Hykes

Andrew Hykes is a declared insider at 2 companies (chief executive); the most frequent names are Inari Medical, Inc. and Shoulder Innovations, Inc. Over a trading history stretching from 19 May 2021 to 5 October 2026, the count stands at 55 filings.

On the market, this insider has only sold: 29 sales, €6.8M in total. The amount is not disclosed for 1 filing. Outside the open market, there are 20 share grants and 5 option exercises.

On 6 October 2026 came the latest disclosure, a share grant for €12k in Shoulder Innovations, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.